Cell-free DNA analysis in maternal plasma in cases of fetal abnormalities detected on ultrasound examination

Obstetrics and Gynecology

Volumn 125, Issue 6, 2015, Pages 1330-1337

  Benachi, Alexandra ^a   Letourneau, Alexandra ^a   Kleinfinger, Pascale ^a   Senat, Marie Victoire ^a   Gautier, Evelyne ^a   Favre, Romain ^a   Bidat, Laurent ^a   Houfflin Debarge, Véronique ^a   Bouyer, Jean ^a   Costa, Jean Marc ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ANEUPLOIDY; ARTICLE; CELL FREE DNA ANALYSIS; CELL FREE SYSTEM; DNA DETERMINATION; DOWN SYNDROME; FEMALE; FETUS DEATH; FETUS ECHOGRAPHY; FETUS KARYOTYPING; HUMAN; MAJOR CLINICAL STUDY; MATERNAL PLASMA; MULTICENTER STUDY; PREGNANCY; PRIORITY JOURNAL; SEX CHROMOSOME ABERRATION; TRIPLOIDY; TRISOMY; TRISOMY 12; TRISOMY 13; TRISOMY 18; TRISOMY 21; BLOOD; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME DISORDER; CLINICAL TRIAL; ECHOGRAPHY; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; KARYOTYPE; LABORATORY DIAGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; X CHROMOSOME;

ADULT; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, X; DNA; DOWN SYNDROME; FALSE NEGATIVE REACTIONS; FEMALE; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; KARYOTYPE; PREGNANCY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEX CHROMOSOME ABERRATIONS; TRISOMY; ULTRASONOGRAPHY, PRENATAL;

EID: 84929853027     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000874     Document Type: Article

References (23)

1. Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:1532-4.
2. Benn P, Borell A, Chiu R Cuckle H, Dugoff L, Faas B, et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2013;33:622-9.
3. Langlois S, Brock JA; Genetics Committee, Wilson RD, Audibert F, Brock JA, et al. Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. J Obstet Gynaecol Can 2013;35:177-83.
4. Gregg AR Gross SJ, Best RG, Monaghan KG, Bajaj K, Skotko BG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013;15:395-8.
5. Devers PL, Cronister A, Ormond KE, Facio F, Brasington CK, Flodman P. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors.J Genet Couns 2013;22:291-5.
6. Jensen TJ, Zwiefelhofer T, Tim RC, Dzakula Z, Kim SK, Mazloom AR et al. High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma. PLoS One 2013;8:e57381.
7. Palomaki GE, Kloza EM, Lambert-Messerlian GM, HaddowJE, Neveux LM, Ehrich M, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-20.
8. Fan HC, Quake SR Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS One 2010;5:e10439.
9. Hudecova I, Sahota D, Heung MM, Jin Y, Lee WS, Leung TY, et al. Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies. PLoS One 2014;9:e88484.
10. Porreco RP, Garite TJ, Maurel K Marusiak B; Obstetrix Collaborative Research Network, Ehrich M, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol 2014;211:365.e1-12.
11. Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, et al. Non-invasive prenatal assessment of trisomy 21 by multiplex maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
12. Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, et al. Non invasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e1-11.
13. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP; MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
14. Dan S, Wang W, Ren J, Li Y, Hu H, Xu Z, et al. Clinical application of massively parallel sequencing based prenatal non invasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn 2012;32:1225-32.
15. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206:319.e1-9.
16. Dar P, Curnow KJ, Gross SJ, Hall MP, Stosic M, Demko Z, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneu-ploidy testing. Am J Obstet Gynecol 2014;211:527.e1-17.
17. Pergament E, Cuckle H, Zimmermann B, Banjevic M, Sigurjonsson S, Ryan A, et al. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol 2014;124:210-8.
18. Palomaki G, Kloza E, Lambert-Messerlian G, van den Boom D, Ehrich M, Deciu C, et al. Circulating cell free DNA testing: are some test failures informative? Prenat Diagn 2015;35:289-93.
19. McCullough RM, Almasri EA, Guan X, Geis JA, Hicks SC, Mazloom AR, et al. Non-invasive prenatal chromosomal aneu-ploidy testing-clinical experience: 100,000 clinical samples. PLoS One 2014;9:e109173.
20. McNamara CJ, Limone LA, Westover T, Miller RC. Maternal source of false-positive fetal sex chromosome aneuploidy in noninvasive prenatal testing. Obstet Gynecol 2015;125:390-2.
21. Rad S, Turner AL, Beauchamp S, Aghajanian P, Williams J III, Esakoff TF. Noninvasive prenatal testing compared with invasive diagnostic testing in the setting of an abnormal state aneu-ploidy screen. Obstet Gynecol 2014;123(suppl 1):100S.
22. Lund IC, Christensen R, Petersen OB, Vogel I, Vestergaard EM. Chromosomal microarray in fetuses with increased nuchal trans-lucency. Ultrasound Obstet Gynecol 2015;45:95-100.
23. The use of chromosomal microarray analysis in prenatal diagnosis. Committee Opinion No. 581. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013; 122:1374-7.